ABUS

ABUS Gross Profit Growth

7821.50%TTM

Period ending:

ABUS TTM Gross Profit YoY %%
ABUS TTM Gross Profit YoY %4114813.31%-38324102.04%
2009-03-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

ABUS gross profit growth history

Year-over-year gross profit growth rate. The available trailing twelve months (ttm) series contains 70 observations from Mar 31, 2009 to Jun 30, 2026.

Arbutus Biopharma Corp Gross Profit Growth — Trailing twelve months (TTM)
Period endingGross Profit Growth
7,821.5045%
1,784.0753%
293.3308%
70.6709%
68.6392%
-148.2744%
-557.3657%
-1,428.5311%
-1,380.3754%
-144.9882%
-96.4095%
-104.2223%
-95.8604%
175.0719%
142.5076%
146.8314%
128.4903%
69.9898%
10.8877%
8.7026%
-14.6288%
2.8269%
17.767%
21.8376%
14.1391%
13.1324%
0.7675%
13.33%
2.0831%
-5.225%
-0.025%
-7.13%
14.5797%
16.4416%
13.0283%
-21.0849%
-43.8671%
-82.4937%
-123.9787%
-39.3959%
-70.0332%
-28.9509%
-12.298%
-104.3978%
-86.1358%
-231.756%
-297.2897%
-58.5169%
-79.213%
-46.421%
-51.8538%
-1,602.7975%
-902.1702%
-102.1781%
-16.0754%
99.9999%
99.9999%
99.9997%
99.9997%
-26,671,818.2636%
-14,327,244.6042%
-19,288,606.7821%
-34,217,110.2301%
645.01%
-266.6079%
-173.2711%
-138.4993%
-106.684%
-65.0798%
-42.4949%

Compare gross profit growth

All ABUS financial metrics · ABUS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.